SPECIAL

Metastasis-directed therapy for oligometastatic RCC in the immunotherapy era

S. Siva

Biomarker-driven prostate cancer care: when prognostic biomarkers surpass predictive biomarkers

D.E. Spratt

Practical issues of next generation sequencing in prostate cancer

R. de Putter

Optimum imaging strategies for advanced prostate cancer: perspectives on the ASCO APC imaging guideline

A. Padhani

Bladder preservation in patients with muscle-invasive bladder cancer

N. Sundahl, N. Martínez Chanzá, J. Catto

New molecules in metastatic urothelial cancer

M. Gizzi

Follow up of early testicular cancer: when and how long?

R. Huddart